Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1109/MPULS.2020.3022203 http://scihub22266oqcxt.onion/10.1109/MPULS.2020.3022203 33064642!ä!33064642 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       IEEE+Pulse 2020 ; 11 (5): 28-31 Nephropedia Template TP {{tp|p=33064642|t=2020. New, At-Home Antibody Test for Detecting, Tracking COVID-19 |pdf=|usr=}}{{33064642}} gab.com Text New, At-Home Antibody Test for Detecting, Tracking COVID-19 JO: IEEE Pulse http://www.kidney.de/pget.php?&tw=1&pmid=33064642 #FOAvip An at-home test for coronavirus disease 2019 (COVID-19) could be released commercially as early as August, according to Scanwell Health of Los Angeles. A combination of a finger-prick blood sample and a smart-phone app, the test is designed to detect the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. The company hopes to receive Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) by the end of summer, and make its first commercially available tests soon after. Twit Text FOAVip New, At-Home Antibody Test for Detecting, Tracking COVID-19 ????IEEE Pulse http://www.kidney.de/pget.php?&tw=1&pmid=33064642 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33064642 #FOAvip English Wikipedia <ref>{{Cite pmid|33064642}}</ref> New, At-Home Antibody Test for Detecting, Tracking COVID-19 #MMPMID33064642 Mertz L IEEE Pulse 2020[Sep]; 11 (5): 28-31 PMID33064642show ga An at-home test for coronavirus disease 2019 (COVID-19) could be released commercially as early as August, according to Scanwell Health of Los Angeles. A combination of a finger-prick blood sample and a smart-phone app, the test is designed to detect the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. The company hopes to receive Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) by the end of summer, and make its first commercially available tests soon after. |Antibodies, Viral/*blood[MESH] |Betacoronavirus/*immunology[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Clinical Laboratory Techniques/instrumentation/*methods[MESH] |Coronavirus Infections/*diagnosis/epidemiology/immunology[MESH] |Humans[MESH] |Mobile Applications[MESH] |Pandemics[MESH] |Patient Participation/methods[MESH] |Pneumonia, Viral/*diagnosis/epidemiology/immunology[MESH] |SARS-CoV-2[MESH]New, At-Home Antibody Test for Detecting, Tracking COVID-19 (epmc).pdf DeepDyve Pubget Overpricing